US-China Decoupling Poses Supply Chain Risks for Drug Companies
A proposed bill in Congress targets Chinese biotech businesses that play an important role in developing drugs.
A proposed bill in Congress targets Chinese biotech businesses that play an important role in developing drugs.
/cloudfront-us-east-1.images.arcpublishing.com/gray/BFMUKWSWURCKTM4CQOY4DVUYOA.jpg)
